Article info

Download PDFPDF

Original research
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration

Authors

  1. Correspondence to Brigitte Michelsen; brigitte.michelsen{at}regionh.dk
View Full Text

Citation

Michelsen B, Lindström U, Codreanu C, et al
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration

Publication history

  • Received April 20, 2020
  • Revision received July 2, 2020
  • Accepted August 21, 2020
  • First published September 19, 2020.
Online issue publication 
July 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.